Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprotinin for Transfusion Requirements in Lung or Esophageal Cancer Surgery
NCT00306137Phase 3Terminated
- Sponsor
- Bayer
- Start
- Dec 2005
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 10
01
Overview
A Phase 3 trial of aprotinin, sponsored by Bayer. Started Dec 2005; status: terminated.
02
Drugs
aprotinin
Beyond the preview
Go deeper on NCT00306137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00306137.